Optimizing recovery in patients with alcohol-related liver cirrhosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial focuses on patients diagnosed with alcohol-related liver cirrhosis, aiming to explore the effectiveness of motivational interviews combined with standard care to promote hepatic recompensation. The study will assess clinical and biochemical markers to predict and monitor improvements in liver function. By addressing the underlying causes of liver disease, the trial seeks to slow disease progression and potentially reverse cirrhosis. Participants will be closely monitored for complications associated with portal hypertension and overall health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Clinical suspicion of cirrhosis related to use of alcohol, supported by biochemistry and ultrasound or other imaging techniques.
* Informed written consent.

Exclusion Criteria:

* The diagnosis of ALC is questioned with reasonable doubt.
* Withdrawal of informed consent or no informed consent.

Where it's running

• Copenhagen University Hospital Hvidovre
  Hvidovre, Capital Region, Denmark Recruiting

Study contacts

• Principal investigator: Nina Kimer, MD, PhD — Gastroenheden, Hvidovre Hospital
• Study coordinator: Nina Kimer, MD, PhD
• Email: nina.kimer@regionh.dk
• Phone: +4538621968

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abbreviated non-contrast MRI versus ultrasound for finding liver cancer in people with cirrhosis

  We will test whether shorter MRI scans without contrast find liver cancer more reliably than routine ultrasound in adults with cirrhosis or otherwise at high risk.

  Recruiting at 2 sites University of Oxford · Oxford, Oxon and 1 other locations · NCT06658782

• Evaluating Cellgram-LC for Alcoholic Cirrhosis Treatment

  This study is testing whether a new treatment using stem cells can help people with alcoholic cirrhosis feel better and improve their liver health.

  Recruiting at 12 sites Phase 3 Pharmicell Co., Ltd. · Ansan and 14 other locations · NCT04689152

• Evaluating SAMe for improving liver function in patients with alcoholic cirrhosis

  This study is testing if a supplement called SAMe can help improve liver function in people with alcoholic cirrhosis.

  Recruiting at 2 sites Phase 2 Indiana University · Los Angeles, California and 1 other locations · NCT04250259

• Understanding genetic factors in alcoholic liver disease

  This study looks at how common alcoholic hepatitis is in people with jaundice and tries to understand the role of genetics in the disease while also testing new ways to diagnose it.

  Recruiting at 9 sites University Hospital, Lille · Angers and 8 other locations · NCT04106518

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.